InvestorsHub Logo
Post# of 4981118
Next 10
Followers 23
Posts 1816
Boards Moderated 0
Alias Born 11/25/2006

Re: None

Wednesday, 11/24/2021 3:45:13 PM

Wednesday, November 24, 2021 3:45:13 PM

Post# of 4981118
$BCLI Important Notes
From Q1 2021 Earnings Call Transcript
Chaim Lebovits: Given the important changes, we are in active dialogue with regulators around our regulatory plan and we will share this as soon as appropriate.

Chaim Lebovits: We cannot get talked to the EAP results. Very warming to hear what you're saying, you're describing. And I do hope that we should be able to share with you some good news very soon.

David Setboun: We are actively engaging with a variety of potential partners, which include mid-sized and leading pharmaceutical companies.

Chaim Lebovits: Looking forward for a very exciting quarter.

Add to that

Senate List 48 sponsors for S.1813 - Accelerating Access to Critical Therapies for ALS Act.
500 Million
"For purposes of carrying out this Act, there are au theorized to be appropriated $100,000,000 for each of fiscal years 2022 through 2026. "

BCLI: Biomarkers Predict Response in ALS Phase 3 Trial
https://www.yahoo.com/now/bcli-biomarkers-predict-response-als-102400354.html

Zacks Small-Cap Research Sets $11 Valuation

Maybe Positive Peer Review

Please add to the list, if you have any...
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.